Board of Directors
Norbert G. Riedel, Ph.D.
Norbert G. Riedel, Ph.D., is corporate vice president and chief scientific officer of Baxter International Inc., having served in that capacity since March 2001. Before assuming this role, Dr. Riedel served as president of the recombinant proteins business unit and vice president of research and development within Baxter's BioScience business. Prior to joining Baxter in 1998, he was head of worldwide biotechnology and core research functions at Hoechst Marion Roussel, now Sanofi-Aventis.
Dr. Riedel received his Ph.D. in biochemistry from the University of Frankfurt in 1983. He was a postdoctoral fellow at Harvard University from 1984-1987, assistant professor and associate professor of medicine and biochemistry at Boston University School of Medicine from 1987-1991 and a visiting professor at Massachusetts Institute of Technology in 1992. He remains affiliated with Boston University as an adjunct professor and also has an adjunct professor of medicine appointment at Northwestern University Feinberg School of Medicine. In 2009, Dr. Riedel was elected into the Austrian Academy of Sciences.
Dr. Riedel serves on the board of directors of Oscient Pharmaceuticals Corporation and Medigene AG. He is the immediate past chairman of the board of directors of the iBIO Institute (the education, training and research arm of iBIO) and a member of the Advisory Board of Northwestern University's Kellogg School of Management Center for Biotechnology. He is also a member of the board of trustees of the Chicago Symphony Orchestra.